Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Gene Therapy With Angiotensin-(1-9) Preserves Left Ventricular Systolic Function After Myocardial Infarction

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Contributors:
      Fattah, Caroline; Nather, Katrin; Mccarroll, Charlotte S.; Hortigon Vinagre, Maria P.; Zamora, Victor; Flores Munoz, Monica; Mcarthur, Lisa; Zentilin, Lorena; Giacca, Mauro; Touyz, Rhian M.; Smith, Godfrey L.; Loughrey, Christopher M.; Nicklin, Stuart A.
    • Publication Date:
      2016
    • Collection:
      Università degli studi di Trieste: ArTS (Archivio della ricerca di Trieste)
    • Abstract:
      BACKGROUND Angiotensin-(1-9) [Ang-(1-9)] is a novel peptide of the counter-regulatory axis of the renin-angiotensin-aldosterone system previously demonstrated to have therapeutic potential in hypertensive cardiomyopathy when administered via osmotic mini-pump. Here, we investigate whether gene transfer of Ang-(1-9) is cardioprotective in a murine model of myocardial infarction (MI). OBJECTIVES The authors evaluated effects of Ang-(1-9) gene therapy on myocardial structural and functional remodeling post-infarction. METHODS C57BL/6 mice underwent permanent left anterior descending coronary artery ligation and cardiac function was assessed using echocardiography for 8 weeks followed by a terminal measurement of left ventricular pressure volume loops. Ang-(1-9) was delivered by adeno-associated viral vector via single tail vein injection immediately following induction of MI. Direct effects of Ang-(1-9) on cardiomyocyte excitation/contraction coupling and cardiac contraction were evaluated in isolated mouse and human cardiomyocytes and in an ex vivo Langendorff-perfused whole-heart model. RESULTS Gene delivery of Ang-(1-9) reduced sudden cardiac death post-MI. Pressure volume measurements revealed complete restoration of end-systolic pressure, ejection fraction, end-systolic volume, and the end-diastolic pressure volume relationship by Ang-(1-9) treatment. Stroke volume and cardiac output were significantly increased versus sham. Histological analysis revealed only mild effects on cardiac hypertrophy and fibrosis, but a significant increase in scar thickness. Direct assessment of Ang-(1-9) on isolated cardiomyocytes demonstrated a positive inotropic effect via increasing calcium transient amplitude and contractility. Ang-(1-9) increased contraction in the Langendorff model through a protein kinase A-dependent mechanism. CONCLUSIONS Our novel findings showed that Ang-(1-9) gene therapy preserved left ventricular systolic function post-MI, restoring cardiac function. Furthermore, Ang-(1-9) directly affected ...
    • Relation:
      info:eu-repo/semantics/altIdentifier/pmid/27978950; info:eu-repo/semantics/altIdentifier/wos/WOS:000389593000009; volume:68; issue:24; firstpage:2652; lastpage:2666; numberofpages:15; journal:JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY; http://hdl.handle.net/11368/2895311; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85003844969; http://www.sciencedirect.com/science/article/pii/S0735109716365755
    • Accession Number:
      10.1016/j.jacc.2016.09.946
    • Online Access:
      http://hdl.handle.net/11368/2895311
      https://doi.org/10.1016/j.jacc.2016.09.946
      http://www.sciencedirect.com/science/article/pii/S0735109716365755
    • Rights:
      info:eu-repo/semantics/openAccess
    • Accession Number:
      edsbas.63E8F49E